Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Hack

Showing results (101-110 of 149) with videos related to

Pageof 15
Sort By:
Archives of Gynecology and Obstetrics|April 11, 2020
Analysis of motives and patient satisfaction in oncological second opinions provided by a certified university breast and gynecological cancer centerChristian R Loehberg, Julia Meyer, Lothar Häberle, et al.
Breast Care (Basel, Switzerland)|July 12, 2021
Analysis of Oncological Second Opinions in a Certified University Breast and Gynecological Cancer Center Regarding Consensus between the First and Second Opinion and Conformity with the GuidelinesMichael P Lux, Sonja Wasner, Julia Meyer, et al.
Reproductive Health|May 16, 2019
Retraction Note: Improving usability and pregnancy rates of a fertility monitor by an additional mobile application: results of a retrospective efficacy study of Daysy and DaysyView appMartin C Koch, Johannes Lermann, Niels van de Roemer, et al.
Reproductive Health|March 4, 2018
Improving usability and pregnancy rates of a fertility monitor by an additional mobile application: results of a retrospective efficacy study of Daysy and DaysyView appMartin C Koch, Johannes Lermann, Niels van de Roemer, et al.
Breast (Edinburgh, Scotland)|June 22, 2021
Mammographic density and prognosis in primary breast cancer patientsFelix Heindl, Peter A Fasching, Alexander Hein, et al.
International Journal of Cancer|July 9, 2016
Mammographic density is the main correlate of tumors detected on ultrasound but not on mammographyLothar Häberle, Peter A Fasching, Barbara Brehm, et al.
International Journal of Cancer|March 7, 2012
Association of mammographic density with hormone receptors in invasive breast cancers: results from a case-only studyKatharina Heusinger, Sebastian M Jud, Lothar Häberle, et al.
European Journal of Cancer (Oxford, England : 1990)|March 5, 2023
Pembrolizumab in combination with nab-paclitaxel for the treatment of patients with early-stage triple-negative breast cancer - A single-arm phase II trial (NeoImmunoboost, AGO-B-041)Peter A Fasching, Alexander Hein, Hans-Christian Kolberg, et al.
Archives of Gynecology and Obstetrics|June 5, 2024
Correlation of RANK and RANKL with mammographic density in primary breast cancer patientsMarius Wunderle, Felix Heindl, Annika S Behrens, et al.
JAMA Neurology|March 29, 2016
Time Course and Diagnostic Accuracy of Glial and Neuronal Blood Biomarkers GFAP and UCH-L1 in a Large Cohort of Trauma Patients With and Without Mild Traumatic Brain InjuryLinda Papa, Gretchen M Brophy, Robert D Welch, et al.
Pageof 15

Showing results (101-110 of 149) with videos related to

Sort By:
Pageof 15
Archives of Gynecology and Obstetrics|April 11, 2020
Analysis of motives and patient satisfaction in oncological second opinions provided by a certified university breast and gynecological cancer centerChristian R Loehberg, Julia Meyer, Lothar Häberle, et al.
Breast Care (Basel, Switzerland)|July 12, 2021
Analysis of Oncological Second Opinions in a Certified University Breast and Gynecological Cancer Center Regarding Consensus between the First and Second Opinion and Conformity with the GuidelinesMichael P Lux, Sonja Wasner, Julia Meyer, et al.
Reproductive Health|May 16, 2019
Retraction Note: Improving usability and pregnancy rates of a fertility monitor by an additional mobile application: results of a retrospective efficacy study of Daysy and DaysyView appMartin C Koch, Johannes Lermann, Niels van de Roemer, et al.
Reproductive Health|March 4, 2018
Improving usability and pregnancy rates of a fertility monitor by an additional mobile application: results of a retrospective efficacy study of Daysy and DaysyView appMartin C Koch, Johannes Lermann, Niels van de Roemer, et al.
Breast (Edinburgh, Scotland)|June 22, 2021
Mammographic density and prognosis in primary breast cancer patientsFelix Heindl, Peter A Fasching, Alexander Hein, et al.
International Journal of Cancer|July 9, 2016
Mammographic density is the main correlate of tumors detected on ultrasound but not on mammographyLothar Häberle, Peter A Fasching, Barbara Brehm, et al.
International Journal of Cancer|March 7, 2012
Association of mammographic density with hormone receptors in invasive breast cancers: results from a case-only studyKatharina Heusinger, Sebastian M Jud, Lothar Häberle, et al.
European Journal of Cancer (Oxford, England : 1990)|March 5, 2023
Pembrolizumab in combination with nab-paclitaxel for the treatment of patients with early-stage triple-negative breast cancer - A single-arm phase II trial (NeoImmunoboost, AGO-B-041)Peter A Fasching, Alexander Hein, Hans-Christian Kolberg, et al.
Archives of Gynecology and Obstetrics|June 5, 2024
Correlation of RANK and RANKL with mammographic density in primary breast cancer patientsMarius Wunderle, Felix Heindl, Annika S Behrens, et al.
JAMA Neurology|March 29, 2016
Time Course and Diagnostic Accuracy of Glial and Neuronal Blood Biomarkers GFAP and UCH-L1 in a Large Cohort of Trauma Patients With and Without Mild Traumatic Brain InjuryLinda Papa, Gretchen M Brophy, Robert D Welch, et al.
Pageof 15